Evogene Ltd. Announces Annual Shareholder Meeting Date
Ticker: EVGN · Form: 6-K · Filed: Jun 17, 2025 · CIK: 1574565
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing
TL;DR
Evogene sets Aug 11 for shareholder meeting - proxy materials out.
AI Summary
Evogene Ltd. has filed a Form 6-K on June 17, 2025, to announce its Annual General Meeting of Shareholders. The meeting is scheduled for August 11, 2025, at 3:00 p.m. Israel time, at Evogene's offices in Rehovot, Israel. The filing includes the notice, proxy statement, and proxy card for the meeting.
Why It Matters
This filing informs shareholders about the upcoming annual meeting where key corporate decisions and elections will be made, allowing them to participate in the governance of Evogene Ltd.
Risk Assessment
Risk Level: low — This is a routine administrative filing announcing a shareholder meeting, with no immediate financial or operational risks indicated.
Key Players & Entities
- Evogene Ltd. (company) — Registrant
- August 11, 2025 (date) — Annual General Meeting date
- June 17, 2025 (date) — Filing date
FAQ
When is the Evogene Ltd. Annual General Meeting of Shareholders scheduled to take place?
The meeting is scheduled for Monday, August 11, 2025.
What time is the Annual General Meeting scheduled for?
The meeting is scheduled for 3:00 p.m. Israel time.
Where will the Annual General Meeting be held?
The meeting will be held at Evogene's offices at 13 Gad Feinstein Street, Rehovot, Israel.
What type of report is Evogene Ltd. filing?
Evogene Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What documents are included with this 6-K filing?
The filing includes a Notice, Proxy Statement, and Proxy Card for the Annual General Meeting of Shareholders.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 17, 2025 regarding Evogene Ltd. (EVGN).